Interleukin-2 in the treatment of HIV disease.
Schwartz
D H
DH
Division of Infectious Diseases, Stanford University Medical Center, CA 94305.
Merigan
T C
TC
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000818:Animals; D005786:Gene Expression Regulation; D006168:Guinea Pigs; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000627:therapeutic use*; D051379:Mice; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis*
D007376:Interleukin-2; D015375:Receptors, Interleukin-2